OrthoPediatrics Statistics
Total Valuation
OrthoPediatrics has a market cap or net worth of $829.27 million. The enterprise value is $895.89 million.
| Market Cap | 829.27M |
| Enterprise Value | 895.89M |
Important Dates
The last earnings date was Tuesday, October 27, 2026, after market close.
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OrthoPediatrics has 26.11 million shares outstanding. The number of shares has increased by 2.18% in one year.
| Current Share Class | 26.11M |
| Shares Outstanding | 26.11M |
| Shares Change (YoY) | +2.18% |
| Shares Change (QoQ) | +0.44% |
| Owned by Insiders (%) | 6.45% |
| Owned by Institutions (%) | 70.49% |
| Float | 18.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.14 |
| Forward PS | 2.81 |
| PB Ratio | 2.44 |
| P/TBV Ratio | 5.65 |
| P/FCF Ratio | 260.78 |
| P/OCF Ratio | 66.37 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 793.52, with an EV/FCF ratio of 281.73.
| EV / Earnings | n/a |
| EV / Sales | 3.39 |
| EV / EBITDA | 793.52 |
| EV / EBIT | n/a |
| EV / FCF | 281.73 |
Financial Position
The company has a current ratio of 4.55, with a Debt / Equity ratio of 0.33.
| Current Ratio | 4.55 |
| Quick Ratio | 1.87 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 15.88 |
| Debt / FCF | 34.86 |
| Interest Coverage | -2.34 |
Financial Efficiency
Return on equity (ROE) is -9.84% and return on invested capital (ROIC) is -2.97%.
| Return on Equity (ROE) | -9.84% |
| Return on Assets (ROA) | -2.68% |
| Return on Invested Capital (ROIC) | -2.97% |
| Return on Capital Employed (ROCE) | -4.75% |
| Weighted Average Cost of Capital (WACC) | 8.75% |
| Revenue Per Employee | $438,762 |
| Profits Per Employee | -$56,284 |
| Employee Count | 602 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 0.51 |
Taxes
In the past 12 months, OrthoPediatrics has paid $294,000 in taxes.
| Income Tax | 294,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +94.01% in the last 52 weeks. The beta is 0.87, so OrthoPediatrics's price volatility has been lower than the market average.
| Beta (5Y) | 0.87 |
| 52-Week Price Change | +94.01% |
| 50-Day Moving Average | 24.06 |
| 200-Day Moving Average | 19.90 |
| Relative Strength Index (RSI) | 70.36 |
| Average Volume (20 Days) | 435,571 |
Short Selling Information
The latest short interest is 977,329, so 3.74% of the outstanding shares have been sold short.
| Short Interest | 977,329 |
| Short Previous Month | 929,989 |
| Short % of Shares Out | 3.74% |
| Short % of Float | 5.36% |
| Short Ratio (days to cover) | 5.19 |
Income Statement
In the last 12 months, OrthoPediatrics had revenue of $264.14 million and -$33.88 million in losses. Loss per share was -$1.42.
| Revenue | 264.14M |
| Gross Profit | 194.84M |
| Operating Income | -21.52M |
| Pretax Income | -33.59M |
| Net Income | -33.88M |
| EBITDA | 1.13M |
| EBIT | -21.52M |
| Loss Per Share | -$1.42 |
Balance Sheet
The company has $44.23 million in cash and $110.85 million in debt, with a net cash position of -$66.62 million or -$2.55 per share.
| Cash & Cash Equivalents | 44.23M |
| Total Debt | 110.85M |
| Net Cash | -66.62M |
| Net Cash Per Share | -$2.55 |
| Equity (Book Value) | 339.35M |
| Book Value Per Share | 12.99 |
| Working Capital | 197.61M |
Cash Flow
In the last 12 months, operating cash flow was $12.50 million and capital expenditures -$9.32 million, giving a free cash flow of $3.18 million.
| Operating Cash Flow | 12.50M |
| Capital Expenditures | -9.32M |
| Depreciation & Amortization | 22.65M |
| Net Borrowing | -3.01M |
| Free Cash Flow | 3.18M |
| FCF Per Share | $0.12 |
Margins
Gross margin is 73.76%, with operating and profit margins of -8.15% and -12.83%.
| Gross Margin | 73.76% |
| Operating Margin | -8.15% |
| Pretax Margin | -12.72% |
| Profit Margin | -12.83% |
| EBITDA Margin | 0.43% |
| EBIT Margin | -8.15% |
| FCF Margin | 1.20% |
Dividends & Yields
OrthoPediatrics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.18% |
| Shareholder Yield | -2.18% |
| Earnings Yield | -4.47% |
| FCF Yield | 0.38% |
Analyst Forecast
The average price target for OrthoPediatrics is $30.75, which is -3.18% lower than the current price. The consensus rating is "Buy".
| Price Target | $30.75 |
| Price Target Difference | -3.18% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 12.72% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OrthoPediatrics has an Altman Z-Score of 1.7 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.7 |
| Piotroski F-Score | 5 |